HUBEI GOTO BIOPHAR financial statements, including revenue, expenses, profit, and loss

The total revenue of 300966 for the last quarter is 131.43 M CNY, and it's 18.13% higher compared to the previous quarter. The net income of Q3 24 is -9.04 M CNY.